We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Philip Schauer

Philip Schauer MD

Professor of Surgery, Cleveland Clinic Lerner College of Medicine; Director, Cleveland Clinic Bariatric and Metabolic Institute (BMI)

Dr. Philip Schauer is Professor of Surgery at the Cleveland Clinic Lerner College of Medicine, and Director of the Cleveland Clinic Bariatric and Metabolic Institute (BMI). He is past president of the American Society for Metabolic & Bariatric Surgery (ASMBS). He is former Chair and founder of Obesity Week, the worlds largest annual meeting devoted to the science of obesity. 

Dr. Schauer's clinical interests include surgery for severe obesity, diabetes and gastrointestinal surgery.  He has performed more than 8000 operations for severe obesity and diabetes.  His research interests include the pathophysiology of obesity and type 2 diabetes, and outcomes of metabolic surgery.

He has authored more than peer reviewed 300 scientific papers, editorials, and textbook chapters, related to obesity, bariatric surgery and gastrointestinal surgery. He is principal investigator of the STAMPEDE trail comparing medical and surgical treatment of diabetes published in New England Journal of Medicine.  He has been principal investigator on 3 NIH funded studies evaluating surgical treatment of diabetes and obesity. He is co-editor of the textbook Minimally Invasive Bariatric Surgery (Second Edition). He has been an invited speaker for more than 200 international lectures on the subject of metabolic surgery. He is past chairman of the Bariatric Surgery Section of the Obesity Society. He is currently Associate editor for the International Journal of Obesity and has been a member of the editorial board of Surgery for Obesity and Related Diseases and Obesity Surgery as well as 3 other scientific journals. He has trained more than 80 fellows in advanced laparoscopic and bariatric surgery. He is the recipient of the Cleveland Clinic 2015 Sones Award – highest honor for scientific innovation at the Cleveland Clinic.


Key References:

Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, Eid G, Mattar S, Ramanathan R, Barinas-Mitchel E, Rao H, Kuller L, Kelley D. Effect of Laparoscopic Roux-en-Y Gastric Bypass on Type II Diabetes Mellitus. Ann Surg. 2003;238(4):467-485.


Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, Thomas S, Abood B, Nissen SE, Bhatt DL. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012 Apr 26;366(17):1567-76..


Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, Navaneethan SD, Singh RP, Pothier CE, Nissen SE, Kashyap SR.  Bariatric Surgery versus Intensive Medical Therapy for Diabetes – 5-Year Outcomes.  N Engl J Med. 2017 Feb 16;376(7):641-65.


Research support: Ethicon, Medtronic, NIH, Paciria,

Advisory Board:  The Medicines Company, Paciria, GI Dynamics, Neurotronic, AMAG

Consultant: Ethicon, Novo Nordisk, Sanofi